CONTINUOUS GLUCOSE MONITORING SYSTEM BASED ON THE FLUORESCENCE METHOD
|
|
|
 |
PURPOSE
The system measures glucose levels in extracellular fluid at intervals of 3–5 minutes. Glycemia is assessed using a subcutaneous implantable sensor of proprietary design. The sensor module operates based on a fluorescence method for determining glucose concentration.
Glucose level data are transmitted via a wearable device to a mobile phone and displayed in the form of graphs, allowing users to assess their condition dynamically.
Built-in software algorithms detect pre-critical and critical conditions and provide recommendations for system users (patients, medical personnel, emergency responders, relatives, etc.).
TECHNICAL SPECIFICATIONS
| Subcutaneous implantable sensor lifetime (not less than), in years | 1 |
| Measured glucose range with at least 10% accuracy, mmol/L | 2...25 |
| Implantable sensor dimensions: | |
| diameter, mm | 3,5 |
| length, mm | 18 |
ADVANTAGES
- original fluorescence-based glucose sensor;
- fundamentally new methods for glycemia data acquisition and processing:
a method for calculating an adaptive glucose measurement interval depending on the current patient status, extending system lifetime;
an algorithm for dynamically determining the range of an individual normal glucose window to improve interpretation accuracy of continuous monitoring data; - comfortable long-term use due to the small size of the implantable sensor;
- no need for regular capillary blood sampling for glycemic control.
DEVELOPERS
R&D Lab. “Medical-purpose devices, systems and technologies”
Production Unitary Enterprise “FreBor” (Borisov, Republic of Belarus)
CONTACTS
Anatoly Osipov
PhD in Technical Sciences, Associate Professor
☏ +375 17 293 86 41
🖂 osipov@bsuir.by
OTHER DEVELOPMENTS
DEVICE FOR GENERATION AND CONTROL OF COLD ATMOSPHERIC PLASMA